Recombinant H5 antigen based on the extracellular domain is able to induce strong immunological response.
Deletion of the multibasic cleavage site in the H5 antigen improves protein oligomerization and its immunogenicity.
Transmission electron microscopy visualized H5 subviral particles.
This new antigen provides clinical protection following the challenge with HP H5N1 strain.